AU2003210386A1 - Pharmaceutical composition comprising a bisphosphonate and a cox-2 inhibitor for the treatment of bone diseases - Google Patents

Pharmaceutical composition comprising a bisphosphonate and a cox-2 inhibitor for the treatment of bone diseases

Info

Publication number
AU2003210386A1
AU2003210386A1 AU2003210386A AU2003210386A AU2003210386A1 AU 2003210386 A1 AU2003210386 A1 AU 2003210386A1 AU 2003210386 A AU2003210386 A AU 2003210386A AU 2003210386 A AU2003210386 A AU 2003210386A AU 2003210386 A1 AU2003210386 A1 AU 2003210386A1
Authority
AU
Australia
Prior art keywords
bisphosphonate
cox
inhibitor
treatment
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003210386A
Other languages
English (en)
Inventor
Zebulun D. Horowitz
Philip Leonard Simon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of AU2003210386A1 publication Critical patent/AU2003210386A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2003210386A 2002-02-28 2003-02-28 Pharmaceutical composition comprising a bisphosphonate and a cox-2 inhibitor for the treatment of bone diseases Abandoned AU2003210386A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0204756.1A GB0204756D0 (en) 2002-02-28 2002-02-28 Organic compounds
GB0204756.1 2002-02-28
PCT/EP2003/002087 WO2003072097A1 (en) 2002-02-28 2003-02-28 Pharmaceutical composition comprising a bisphosphonate and a cox-2 inhibitor for the treatment of bone diseases

Publications (1)

Publication Number Publication Date
AU2003210386A1 true AU2003210386A1 (en) 2003-09-09

Family

ID=9932008

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003210386A Abandoned AU2003210386A1 (en) 2002-02-28 2003-02-28 Pharmaceutical composition comprising a bisphosphonate and a cox-2 inhibitor for the treatment of bone diseases

Country Status (9)

Country Link
US (1) US20050209198A1 (enExample)
EP (1) EP1480637A1 (enExample)
JP (1) JP2005523291A (enExample)
CN (1) CN1638759A (enExample)
AU (1) AU2003210386A1 (enExample)
BR (1) BR0308105A (enExample)
CA (1) CA2477347A1 (enExample)
GB (1) GB0204756D0 (enExample)
WO (1) WO2003072097A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040053900A1 (en) * 1998-12-23 2004-03-18 Pharmacia Corporation Method of using a COX-2 inhibitor and an aromatase inhibitor as a combination therapy
CN107540726A (zh) * 2017-08-22 2018-01-05 河北科技大学 一类肽基塞来昔布衍生物及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2294879A (en) * 1994-10-19 1996-05-15 Merck & Co Inc Cylcooxygenase-2 Inhibitors
WO2000028982A2 (en) * 1998-11-19 2000-05-25 The Board Of Trustees For The University Of Arkansas Increasing bone strength with selected bisphosphonates
AU783992B2 (en) * 1998-12-23 2006-01-12 G.D. Searle Llc Method of using a cyclooxygenase-2 inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
NZ523086A (en) * 2000-06-20 2007-07-27 Novartis Ag Method of administering bisphosphonates
ES2301710T3 (es) * 2001-10-19 2008-07-01 Novartis Ag Composicion farfamaceutica para el uso en el tratamiento de malignidades que comprenden en combinacion un bisfosfonato, un inhibidor de cox-2 y un taxol.

Also Published As

Publication number Publication date
GB0204756D0 (en) 2002-04-17
JP2005523291A (ja) 2005-08-04
BR0308105A (pt) 2005-01-04
CA2477347A1 (en) 2003-09-04
CN1638759A (zh) 2005-07-13
EP1480637A1 (en) 2004-12-01
WO2003072097A1 (en) 2003-09-04
US20050209198A1 (en) 2005-09-22

Similar Documents

Publication Publication Date Title
AU2003297621A1 (en) Medical devices for delivery of therapeutic agents
AU2003251563A1 (en) Implatable or insertable medical devices for controlled delivery of a therapeutic agent
AU2003270903A1 (en) A video game for assisting healing of the human body
AU2003264038A1 (en) Combination pharmaceutical agents as inhibitors of hcv replication
AU2003223579A1 (en) Combinations of cox-2 inhibitors and other agents for the treatment of parkinson's disease
AU2002243023A1 (en) Compositions for preventing and/or treating oral diseases
AU2003229923A1 (en) Curcumin for the prevention and/or treatment of tissue damage
AU2003272472A1 (en) Use of beta glucans for the treatment of osteoporosis and other diseases of bone resorption
AU2002248319A1 (en) Pharmaceutical composition for the prevention and treatment of scar tissue
AU2002323823A1 (en) Medicament for prevention and treatment of fracture and osteoporosis
AU2003243439A1 (en) Medical device for intra-lumenal delivery of pharmaceutical agents
AU2003276572A1 (en) Pharmaceutical dosage forms of biguanide-sulfonylurea combinations
AU2003290799A1 (en) 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
AU2003232257A1 (en) Resorbable pharmaceutical formulation for the continuous release of thrombin
AU2003211610A1 (en) Pharmaceutical compositions for the treatment or prevention of osteoporosis
AU2003246592A1 (en) Tumour marker and the use thereof for the diagnosis and treatment of tumour diseases
AU2003210386A1 (en) Pharmaceutical composition comprising a bisphosphonate and a cox-2 inhibitor for the treatment of bone diseases
AU2003213898A1 (en) Prevention and treatment of mycoplasma-associated diseases
AU2003264954A1 (en) Pharmaceutical composition for prevention and treatment of kidney diseases
AU2003268939A1 (en) Bisphosphonates for the treatment of antheroscleorosis and devices comprising them
GB0201025D0 (en) The treatment of degenerative diseases
AU2003236787A1 (en) Use of alkylphosphocholines for the preventative treatment of protozoan diseases
AU2003227524A1 (en) Use of bisphosphonic acid derivatives for the treatment of calcium phrophosphated deposition disease and dental treatment
AU2002343085A1 (en) Tnf-alpha inhibitors for the treatment of hepatic diseases
AU2003264397A1 (en) Preventive and/or therapeutic drugs for inflammatory intestinal diseases

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase